Amedisys (NASDAQ:AMED) Announces Quarterly Earnings Results, Beats Estimates By $0.01 EPS

Amedisys (NASDAQ:AMEDGet Free Report) released its quarterly earnings data on Wednesday. The health services provider reported $1.03 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.02 by $0.01, Briefing.com reports. Amedisys had a positive return on equity of 13.00% and a negative net margin of 0.91%. The firm had revenue of $571.41 million for the quarter, compared to analyst estimates of $565.38 million. During the same quarter in the prior year, the company earned $1.00 earnings per share. The business’s revenue for the quarter was up 2.7% compared to the same quarter last year.

Amedisys Trading Up 0.1 %

Shares of AMED opened at $91.16 on Friday. Amedisys has a 1 year low of $73.10 and a 1 year high of $96.44. The company has a quick ratio of 1.05, a current ratio of 1.05 and a debt-to-equity ratio of 0.32. The stock has a 50 day simple moving average of $92.57 and a two-hundred day simple moving average of $93.35.

Wall Street Analysts Forecast Growth

A number of analysts have recently issued reports on the company. Royal Bank of Canada raised their price objective on Amedisys from $97.00 to $100.00 and gave the company an “outperform” rating in a research report on Monday, March 25th. StockNews.com started coverage on Amedisys in a research report on Monday, April 8th. They issued a “buy” rating on the stock. Raymond James reaffirmed a “market perform” rating on shares of Amedisys in a research note on Tuesday, March 26th. Finally, Cantor Fitzgerald reissued a “neutral” rating and set a $101.00 price objective on shares of Amedisys in a report on Thursday. Seven research analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $97.50.

Get Our Latest Stock Report on AMED

Amedisys Company Profile

(Get Free Report)

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.

Featured Articles

Earnings History for Amedisys (NASDAQ:AMED)

Receive News & Ratings for Amedisys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amedisys and related companies with MarketBeat.com's FREE daily email newsletter.